- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7373
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immune suppression in gliomas ; day:15 ; month:6 ; year:2020 ; pages:1-10
Journal of neuro-oncology ; (15.6.2020), 1-10
- Urheber
-
Grabowski, Matthew M.
Sankey, Eric W.
Ryan, Katherine J.
Chongsathidkiet, Pakawat
Lorrey, Selena J.
Wilkinson, Daniel S.
Fecci, Peter E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11060-020-03483-y
- URN
-
urn:nbn:de:101:1-2020081301065881188094
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Grabowski, Matthew M.
- Sankey, Eric W.
- Ryan, Katherine J.
- Chongsathidkiet, Pakawat
- Lorrey, Selena J.
- Wilkinson, Daniel S.
- Fecci, Peter E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immune cell dynamics in irradiated gliomas
Therapeutic approaches to modulate the immune microenvironment in gliomas
Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas
Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas
Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas
Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
Lower Grade Gliomas
Editorial: Exosome-mediated intercellular communications: immune stimulation and suppression
Correction to: Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas
Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas
HOXC6 impacts epithelial-mesenchymal transition and the immune microenvironment through gene transcription in gliomas
Immune cell dynamics in irradiated gliomas
Therapeutic approaches to modulate the immune microenvironment in gliomas
Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas
Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas
Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas
Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
Lower Grade Gliomas
Editorial: Exosome-mediated intercellular communications: immune stimulation and suppression
Correction to: Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas
Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas
HOXC6 impacts epithelial-mesenchymal transition and the immune microenvironment through gene transcription in gliomas
Immune cell dynamics in irradiated gliomas
Therapeutic approaches to modulate the immune microenvironment in gliomas
Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas
Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas
Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas
Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
Lower Grade Gliomas
Editorial: Exosome-mediated intercellular communications: immune stimulation and suppression
Correction to: Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas
Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas